Immunotherapy in Cancer Treatment

Immunotherapy in Cancer Treatment

Contact hours
4.10
On Demand

Immunotherapy, believed to be the most promising new form of cancer treatment since the emergence of chemotherapy, is now being celebrated as a top advancement in cancer care. Encouraging clinical trial results involving the use of immunotherapy continue to yield more approved indications for various cancer types. Even as more agents emerge, immunotherapy drug use is expected to further expand as we move toward the future of cancer treatment.

The ONS Immunotherapy online course is a first of its kind. Designed from a clinical perspective, the program educates oncology nurses and other healthcare providers how immunotherapy drugs reprogram the immune system to identify and target cancer cells. Detailed case studies will further address administration and care considerations for patients undergoing treatment with the various classes of immunotherapy.

Offered on demand, instructions on how to immediately access the course will be sent to you in an automatically generated email receipt after you register. You will enjoy continuous access to course content and materials for six months. Other resources can be downloaded for indefinite use.

Immunotherapy in Cancer Treatment Course Topics

  • Immune System Overview
  • Introduction to Immunotherapy
  • Classes of Immunotherapy (Monoclonal Antibodies, Vaccines, Cytokines, Adoptive T-cell Transfer, Checkpoint Inhibitors)
  • Combination Therapy
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Hematologic Malignancies
  • Metastatic Melanoma
  • Renal Cell Carcinoma
  • Nursing and Patient Support Education

Expected Outcome

Upon completion of this activity, the learner will incorporate key principles of immunotherapy into decisions related to safe and effective management of people with cancer receiving immunotherapy agents.

Target Audience

This course is designed to meet the educational needs of oncology nurses and other healthcare professionals caring for patients receiving immunotherapy as part of cancer treatment.

ILNA Breakdown

CBCN® and CPHON®
4.1 ILNA points may be applied toward:

  • 3 points: Treatment Modalities
  • 1.1 points: Symptom Management

AOCNP® and AOCNS®
4.1 ILNA points may be applied toward:

  • up to 3.1 points: Treatment Modalities
  • up to 1.1 points: Symptom Management

OCN®
4.1 ILNA points may be applied toward:

  • 1 point: Scientific Basis/Diagnosis
  • 2.1 points: Treatment Modalities
  • 1 point: Symptom Management

BMTCN™
4.1 ILNA points may be applied toward:

  • 4.1 points: Basic Concepts and Indications for Transplantation
Learning Objectives
  • Describe how the immune system can be used to prevent, detect, and treat cancer
  • Communicate to patients the available data on the classes of immunotherapy with regard to mechanism of action and clinical implications of therapy.
  • Incorporate immunotherapy administration considerations into practice to promote quality cancer care
  • Explain the side effects of cancer immunotherapy and evidence-based interventions to manage them.

The Oncology Nursing Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

Individual Pricing Options

$40.00
Member
$90.00
Nonmember

Group purchases are available

 Registering for 10 or more people? Group discounts are available for this course.

To find out more, contact ONS customer service at help@ons.org or 866-257-4667, option 2. Our office hours are Monday through Friday from 8:30 am–5 pm EST.

How to Sign Up
1 Log In
2 Review Policies

Menu